Enfusion

Enfusion P/TBV

Delisted

The Price to Tangible Book Value (P/TBV) of Enfusion (ENFN) as of Nov 7, 2026 is 19.08. In the previous year, Price to Tangible Book Value (P/TBV) was 26.03 — a change of -26.71% (lower).

P/TBV

19.08

YoY

-26.71%

Last updated:

Price to Tangible Book Value (P/TBV) of Enfusion is 2024 19.08 . Price to Tangible Book Value (P/TBV) of Enfusion was 2023 26.03 . It decreases by -26.71% lower compared to the previous year.

The Enfusion P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2019
-11.85 USD
Jan 1, 2020
-5.98 USD
Jan 1, 2021
25.27 USD
Jan 1, 2022
21.49 USD
Jan 1, 2023
26.03 USD
Jan 1, 2024
19.08 USD
The Enfusion P/TBV history
YEARP/TBVYoY
19.08-26.71%
26.03+21.13%
21.49-14.94%
25.27-522.40%
-5.98-49.53%
-11.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Price to Tangible Book Value (P/TBV) of Enfusion is 19.08 in 2024.

Price to Tangible Book Value (P/TBV) of Enfusion changed from 26.03 to 19.08, representing a -26.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Enfusion since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enfusion

All Key Metrics — Enfusion